Sydney: The 7th International Yeast 2.0 and Synthetic Genomes Conference

Looking to the future
Sydney: The 7th International Yeast 2.0 and Synthetic Genomes Conference
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

 Who will lead synthetic biology in the future and where will they lead it?  This is the question that opened the 7th International Yeast 2.0 Synthetic Genomes Conference and in many ways was the theme that helped to tie together the three days in Sydney. 

 

The conference started not with a key note address but with the poster presentation, giving young researchers a chance to be front and centre in talking about their work.  After all, the PhD students and postdocs in the room would be the ones guiding the field as it confronts the big questions of the 21st century.

 

The focus on the future continued on with how to build a bioeconomy.  Synthetic biology is not purely focused on company spin-offs or industrial strategy but sees the need to build an economy that is circular and carbon neutral.  Long-term survival of advanced human societies depends on it.

 

How was synthetic biology pushing the limits of the possible?  What risks did this entail?  This what the second day focused on.   One of the things I really appreciate and value about the synthetic biology community is its engagement with the social, political and ethical aspects of the work being done.   The community casts a self-critical eye on itself and doesn’t avoid asking questions about how this might affect the world and – in doing so – asking how not only to communicate to the public but how to engage the public for their consent. 

 

Finally, the last day looked to the far horizon, where new possibilities open up including synthetic genomes.  Synthetic biology, by reshaping and redesigning living systems, blurs the definitions we have grown comfortable with. 

 

Comfort being something in short supply recently.  It was during the conference that the announcement of CRISPR-edited human babies was made in Hong Kong.   Unsurprisingly this dominated several conversations and discussions both in and outside the conference hall.   I was on my phone during a coffee break catching up on the news and thought to myself that it felt like the world had shifted in some fundamental way.  The Age of Biology had truly arrived.

 

So more than ever it’s important we look towards the future and grapple with the scientific, technical, moral, ethical, social, cultural and legal ramifications of the work being done.   The community has built engagement with these concerns into its DNA and it is essential that they are part of the core training of the next generation of synthetic biologists.   It is reassuring that as part of my tour around Australia – and everywhere I have been in the synthetic biology world – these matters are given serious thought and consideration.

 

  After all, to steal a quote from Spiderman, “With great power comes great responsibility.”  

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With collections, you can get published faster and increase your visibility.

Advances in catalytic hydrogen evolution

This collection encourages submissions related to hydrogen evolution catalysis, particularly where hydrogen gas is the primary product. This is a cross-journal partnership between the Energy Materials team at Nature Communications with Communications Chemistry, Communications Engineering, Communications Materials, and Scientific Reports. We seek studies covering a range of perspectives including materials design & development, catalytic performance, or underlying mechanistic understanding. Other works focused on potential applications and large-scale demonstration of hydrogen evolution are also welcome.

Publishing Model: Open Access

Deadline: Sep 30, 2024

Cancer epigenetics

With this cross-journal Collection, the editors at Nature Communications, Communications Biology, Communications Medicine, and Scientific Reports invite submissions covering the breadth of research carried out in the field of cancer epigenetics. We will highlight studies aiming at the improvement of our understanding of the epigenetic mechanisms underlying cancer initiation, progression, response to therapy, metastasis and tumour plasticity as well as findings that have the potential to be translated into the clinic.

Publishing Model: Open Access

Deadline: Oct 31, 2024